SGRY 📈 Surgery Partners - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US86881A1007
SGRY: Surgical, Diagnostic, Ancillary, Medical, Healthcare
Surgery Partners Inc, a leading healthcare services company, operates a diverse network of surgical facilities and ancillary services across the United States. Through its subsidiaries, the company provides a range of ambulatory surgery centers and surgical hospitals, offering non-emergency surgical procedures in various specialties such as orthopedics, pain management, ophthalmology, gastroenterology, and general surgery. This enables patients to receive specialized care in a more personalized and cost-effective setting.
The company's comprehensive service portfolio includes diagnostic imaging, laboratory services, obstetrics, oncology, pharmacy, physical therapy, and wound care, catering to a broad spectrum of patient needs. Additionally, Surgery Partners offers ancillary services like multi-specialty physician practices, urgent care facilities, and anesthesia services, further enhancing the quality and accessibility of care. Its single- and multi-specialty facilities are designed to provide flexible and efficient solutions for patients and healthcare providers alike, streamlining the delivery of medical services.
Founded in 2004, Surgery Partners has established itself as a significant player in the healthcare industry, with its headquarters located in Brentwood, Tennessee. The company's commitment to delivering high-quality, patient-centered care has enabled it to build a strong reputation and expand its operations across the country. With its common stock listed on the NASDAQ exchange under the ticker symbol SGRY, and classified under the GICS Sub Industry of Health Care Facilities, Surgery Partners continues to focus on driving growth, innovation, and excellence in the healthcare services sector.
Additional Sources for SGRY Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SGRY Stock Overview
Market Cap in USD | 2,746m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2015-10-01 |
SGRY Stock Ratings
Growth 5y | 9.33% |
Fundamental | 7.73% |
Dividend | - |
Rel. Strength Industry | -2281 |
Analysts | 4.33/5 |
Fair Price Momentum | 18.89 USD |
Fair Price DCF | 33.26 USD |
SGRY Dividends
No Dividends PaidSGRY Growth Ratios
Growth Correlation 3m | -92% |
Growth Correlation 12m | -36.6% |
Growth Correlation 5y | 8% |
CAGR 5y | 7.03% |
CAGR/Mean DD 5y | 0.19 |
Sharpe Ratio 12m | -0.71 |
Alpha | -88.35 |
Beta | 2.33 |
Volatility | 57.04% |
Current Volume | 656.5k |
Average Volume 20d | 1038.4k |
As of January 10, 2025, the stock is trading at USD 21.23 with a total of 656,543 shares traded.
Over the past week, the price has changed by -0.28%, over one month by -4.58%, over three months by -28.49% and over the past year by -36.21%.
Neither. Based on ValueRay Fundamental Analyses, Surgery Partners is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 7.73 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SGRY as of January 2025 is 18.89. This means that SGRY is currently overvalued and has a potential downside of -11.02%.
Surgery Partners has received a consensus analysts rating of 4.33. Therefor, it is recommend to buy SGRY.
- Strong Buy: 7
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, SGRY Surgery Partners will be worth about 20.8 in January 2026. The stock is currently trading at 21.23. This means that the stock has a potential downside of -2.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 34.9 | 64.6% |
Analysts Target Price | 46.8 | 120.3% |
ValueRay Target Price | 20.8 | -2.2% |